Comparative Proteomic of Cervical Carcinoma Tissues at Differential Clinical Stages

ZHU Hong,ZHOU Chuan-yi,YUAN Jun,CAO Hui,YI Qiong,LIU Li
DOI: https://doi.org/10.3971/j.issn.1000-8578.2010.12.019
2010-01-01
Abstract:Objective Cervical carcinoma clinical stages associated proteins would be found by comparing differential expressed proteins from differential clinical stage cervical carcinoma tissues.MethodsTotal protein from cervical carcinoma tissues was extracted; differential proteome profiles were established and analysized by means of immobilized pH gradient-based two-dimensional polyacrylamide gel electrophoresis(2D-PAGE) and matrix-assisted laser desorption/ionization time of flight mass spectrometry(MALDI-TOF-MS).HSP70 and Galectin-7 expression were assayed by Western Blot and immunohistochemical technique.Results Well-resolved reproducible 2-DE profiles of human cervical carcinoma tissues were obtained.Average protein dots were(1 098±23),(1 142±21) at early-stage and medium-advanced stage respectively; By analysis with mass spectrometry and bioinformatics,12 of them were well characterized.4 proteins were over-expressed in early-stage group,including Hemoglobin subunit beta HB,caspase-14,Galectin-7,CK19; 8 protein were over-expressed in medium-advanced stage,including Lamin-B1,Flavin reductase、Glutamate dehydrogenase 1,Retinal dehydrogenase 1,NMP238,HSP70,Calmodulin-like 5,S100A9.HSP70 expressed higher at medium-advanced stage group than at early-stage group and Galectin-7 expressed higher at early-stage group than at medium-advanced group.Conclusion Differential expressed proteins exist in clinical stage of cervical carcinoma,which would be biomarkers for diagnosis and prediction of prognosis.
What problem does this paper attempt to address?